Chief Development Officer · OCULAR THERAPEUTIX, INC (OCUL)

Peter Kaiser

FY2024 is the first fiscal year CompBrief holds for Peter Kaiser as a named executive officer of OCULAR THERAPEUTIX; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$6,629,358

Salary $365,054Stock awards $3,875,988Bonus $242,000

3rd of 5 named executive officers at Ocular Therapeutix by FY2024 total.

5 named officers on file for OCULAR THERAPEUTIX, FY2024

Peter Kaiser’s pay file — $29

  • 1 fiscal year of pay, line by line
  • OCUL’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how OCULAR THERAPEUTIX’s whole pay program stands against its peers

  • OCULAR THERAPEUTIX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OCUL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Peter Kaiser’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Peter Kaiser compensation by year

OCULAR THERAPEUTIX Summary Compensation Table · the one fiscal year held
In US dollars, as OCULAR THERAPEUTIX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$365,054
Bonus$242,000
Stock awards$3,875,988
Option awards$2,116,553
Non-equity incentive$0
Pension and deferred compensation$0
All other$29,753
Total$6,629,358

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 29, 2025, accession 0001558370-25-005868, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OCULAR THERAPEUTIX, INC filed document, accession 0001558370-25-005868. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU100,000$854,000—
RSU91,666$782,828—
Option70,836—$3.36
Option191,667—$9.31
Option366,666—$9.70

Per the Outstanding Equity Awards at Fiscal Year-End table in OCULAR THERAPEUTIX, INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

10 Form 4 lines since the FY2024 proxy (filed April 29, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-02Sale10b5-19,990$7.05254,388
2026-08-24Sale10b5-13,035$10.77264,378
2026-05-26Sale10b5-12,967$8.20266,141
2026-02-23Sale10b5-12,810$8.28269,108
2026-01-02Grant or award derivative—240,932$0.00240,932
2026-01-02Grant or award—79,112$0.00271,918
2025-11-24Sale10b5-13,007$12.02191,433
2025-10-02Sale10b5-19,653$11.03194,440

The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

OCULAR THERAPEUTIX’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Pravin DugelExecutive Chair, President and Chief Executive Officer (3)$18,574,830
Antony MattessichFormer President and Chief Executive Officer$8,782,364
Peter Kaiser · this pageChief Development Officer$6,629,358
Jeffrey HeierChief Scientific Officer$6,599,173
Donald NotmanChief Operating Officer and Chief Financial Officer$2,069,341

The full OCULAR THERAPEUTIX compensation record

free company brief

This page is one person within OCULAR THERAPEUTIX's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the OCULAR THERAPEUTIX proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCULAR THERAPEUTIX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Peter Kaiser's compensation dossier · One-time report. No refunds.